These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16978752)

  • 1. Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia.
    Stip E; Langlois R; Thuot C; Mancini-Marïe A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):297-300. PubMed ID: 16978752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agents.
    Wu SY; Liu CC; Hsieh MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1089-90. PubMed ID: 18407390
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
    Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS
    Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
    Sayin A; Cosar B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
    Raveendranathan D; Sharma E; Venkatasubramanian G; Rao MG; Varambally S; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(5):574.e5-6. PubMed ID: 22902258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
    Vila-Rodriguez F; Tsang P; Barr AM
    Am J Psychiatry; 2013 Oct; 170(10):1213-4. PubMed ID: 24084822
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine-induced agranulocytosis in systemic lupus erythematosus: a case report.
    Su JA; Wu CH; Tsang HY
    Gen Hosp Psychiatry; 2007; 29(1):75-7. PubMed ID: 17189752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A; Borkar HA; Chandak S
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia.
    Montgomery J
    Gen Hosp Psychiatry; 2006; 28(1):83-5. PubMed ID: 16377373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chlorpromazine-induced agranulocytosis: a case report].
    Stephan F; Podlipski MA; Kerleau JM; Petit M; Guillin O
    Encephale; 2009 Apr; 35(2):173-5. PubMed ID: 19393387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of rechallenge clozapine after agranulocytosis: A case report.
    Roméo B; Petillion A; Martelli C; Benyamina A
    Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible neutropenia during treatment with olanzapine: three case reports.
    Cordes J; Streit M; Loeffler S; von Wilmsdorff M; Agelink M; Klimke A
    World J Biol Psychiatry; 2004 Oct; 5(4):230-4. PubMed ID: 15543518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL; Yim PH
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis.
    Ng W; Kennar R; Uetrecht J
    Chem Res Toxicol; 2014 Jul; 27(7):1104-8. PubMed ID: 24968069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment.
    Oglodek E; Szota A; Araszkiewicz A
    Aust N Z J Psychiatry; 2013 Oct; 47(10):972. PubMed ID: 23630396
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine-induced agranulocytosis: a case report and review of the literature.
    Tolosa-Vilella C; Ruiz-Ripoll A; Mari-Alfonso B; Naval-Sendra E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):411-4. PubMed ID: 11817522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of olanzapine-induced reversible neutropenia.
    Steinwachs A; Grohmann R; Pedrosa F; Rüther E; Schwerdtner I
    Pharmacopsychiatry; 1999 Jul; 32(4):154-6. PubMed ID: 10505486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine?
    Dettling M; Cascorbi I; Hellweg R; Deicke U; Weise L; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1999 May; 32(3):110-2. PubMed ID: 10463379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.